S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Steven H. Bernstein, MD
James P. Wilmot Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
204 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Aurora Presbyterian Hospital
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado, United States
- Ccop - Colorado Cancer Research Program
Denver, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - St. Luke'S Medical Center
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- St. Anthony Central Hospital
Denver, Colorado, United States
- St. Joseph Hospital
Denver, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- North Colorado Medical Center
Greeley, Colorado, United States
- Littleton Adventist Hospital
Littleton, Colorado, United States
- Sky Ridge Medical Center
Lone Tree, Colorado, United States
- Hope Cancer Care Center at Longmont United Hospital
Longmont, Colorado, United States
- Mckee Medical Center
Loveland, Colorado, United States
- Parker Adventist Hospital
Parker, Colorado, United States
- St. Mary - Corwin Regional Medical Center
Pueblo, Colorado, United States
- Exempla Lutheran Medical Center
Wheat Ridge, Colorado, United States
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Florida Hospital Cancer Institute at Florida Hospital Orlando
Orlando, Florida, United States
- St. Joseph Regional Medical Center
Lewiston, Idaho, United States
- Illinois Cancercare - Bloomington
Bloomington, Illinois, United States
- Graham Hospital
Canton, Illinois, United States
- Illinois Cancercare - Canton
Canton, Illinois, United States
- Illinois Cancercare - Carthage
Carthage, Illinois, United States
- Memorial Hospital
Carthage, Illinois, United States
- Hematology and Oncology Associates
Chicago, Illinois, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- Decatur Memorial Hospital Cancer Care Institute
Decatur, Illinois, United States
- Eureka Community Hospital
Eureka, Illinois, United States
- Illinois Cancercare - Eureka
Eureka, Illinois, United States
- Galesburg Clinic, Pc
Galesburg, Illinois, United States
- Illinois Cancercare - Galesburg
Galesburg, Illinois, United States
- Illinois Cancercare - Havana
Havana, Illinois, United States
- Mason District Hospital
Havana, Illinois, United States
- Kellogg Cancer Care Center
Highland Park, Illinois, United States
- Provena St. Mary'S Regional Cancer Center - Kankakee
Kankakee, Illinois, United States
- Illinois Cancercare - Kewanee Clinic
Kewanee, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2011
- Primary completion
- 29 Feb 2016
- Completion
- 31 Mar 2021
- Last update posted
- 29 Oct 2021
- Registered enrollment
- 53
- Registry id
- NCT01412879
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.